Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis (Cancer Cell International, (2021), 21, 1, (426), 10.1186/s12935-021-02100-w)

Abstract

Following the publication of the original article [1], we were notified that the affiliation of the third author was incorrect. Originally published affiliation: Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China Corrected affiliation: Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China The original article has been corrected.